GLIMEPIRIDE 2MG+METFORMIN HCL (SR) 500MG+PIOGLITAZONE HCL 15MG

Name: GLIMEPIRIDE 2MG+METFORMIN HCL (SR) 500MG+PIOGLITAZONE HCL 15MG
Brand: MACRO LABS PVT. LTD.
Price: 1125 INR
Availability: InStock

Price 1125 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

GLIMEPIRIDE 2MG+METFORMIN HCL (SR) 500MG+PIOGLITAZONE HCL 15MG Specification

Generic Name
GLIMEPIRIDE 2MG + METFORMIN HCL (SR) 500MG + PIOGLITAZONE HCL 15MG

Form
Tablet

Side Effects
Hypoglycemia, gastrointestinal disturbance, edema, weight gain, headache

Shelf Life
24 months

Storage
Store in a cool, dry place below 25C, protect from light and moisture

Administration Route
Oral

Strength
GLIMEPIRIDE 2MG, METFORMIN (SR) 500MG, PIOGLITAZONE 15MG

Packaging Type
Box

Composition
Glimepiride 2mg, Metformin Hydrochloride (Sustained Release) 500mg, Pioglitazone Hydrochloride 15mg

Indications
Management of type 2 diabetes not controlled by diet and exercise alone

Drug Schedule
Schedule H (Prescription Required)

Type Of Medicines
Allopathic

Contraindications
Hypersensitivity to any component, type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment

Prescription/Non prescription
Prescription

Therapeutic Class
Antidiabetic Combination

Packaging Size
10x10 Tablets

Usage/Application
For the treatment of Type 2 Diabetes Mellitus

GLIMEPIRIDE 2MG+METFORMIN HCL (SR) 500MG+PIOGLITAZONE HCL 15MG Trade Information

Minimum Order Quantity
10 Boxes

Main Domestic Market
All India

About GLIMEPIRIDE 2MG+METFORMIN HCL (SR) 500MG+PIOGLITAZONE HCL 15MG

Glimepiride + Metformin + Pioglitazone is a combination of three antidiabetic medicines: Glimepiride , Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity.

Optimized Triple Therapy for Type 2 Diabetes

This tablet combines Glimepiride, Metformin (Sustained Release), and Pioglitazone, targeting multiple mechanisms to improve glycemic control in individuals with type 2 diabetes. The integrated approach enhances insulin sensitivity and reduces hepatic glucose output, making it suitable for patients requiring intensified therapy beyond single or dual medication regimens.

Guidelines for Safe Use and Storage

To maintain efficacy, the tablets should be stored below 25C, away from moisture and direct sunlight. It is important to keep the product in its original packaging and out of reach of children. Always take the medicine strictly as prescribed, and never share it with others, as improper use can lead to serious health risks.

FAQ's of GLIMEPIRIDE 2MG+METFORMIN HCL (SR) 500MG+PIOGLITAZONE HCL 15MG:

Q: How should GLIMEPIRIDE 2MG+METFORMIN HCL (SR) 500MG+PIOGLITAZONE HCL 15MG tablets be taken?

A: Take the tablet orally with a glass of water, usually once daily with food, as prescribed by your doctor. Adhering to the recommended timing helps minimize gastrointestinal discomfort and optimizes blood glucose control.

Q: What are the advantages of using this antidiabetic combination therapy?

A: The combination provides multiple mechanisms of action-Glimepiride increases insulin secretion, Metformin reduces liver glucose production, and Pioglitazone improves insulin sensitivity-offering robust glycemic management for type 2 diabetes patients uncontrolled by diet or single medications.

Q: Where should I store these tablets to ensure their stability?

A: Store the tablets in a cool, dry environment below 25C, protected from moisture and direct light. Always keep the medication in its original box until use to preserve its effectiveness throughout the 24-month shelf life.

Q: When should this combination therapy be considered?

A: GLIMEPIRIDE+METFORMIN (SR)+PIOGLITAZONE is prescribed for type 2 diabetes mellitus patients who have not achieved adequate glycemic control with diet, exercise, and either monotherapy or dual therapy. It is not intended for type 1 diabetes or diabetic ketoacidosis.

Q: What potential side effects should I be aware of?

A: Possible side effects include low blood sugar (hypoglycemia), gastrointestinal symptoms (such as nausea or diarrhea), swelling (edema), weight gain, and headache. Notify your healthcare provider if any side effects are persistent or severe.

Q: Who should avoid taking this medication?

A: This product should not be taken by individuals with hypersensitivity to any component, those with type 1 diabetes, diabetic ketoacidosis, or patients with severe kidney or liver impairment. Consult your doctor for a thorough assessment before starting therapy.

Tell us about your requirement